Neumora Therapeutics, Inc. Common Stock (NMRA) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Neumora Therapeutics, Inc. Common Stock (NMRA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $329.8M, listed on NASDAQ, employing roughly 110 people, carrying a beta of 3.05 to the broader market. Neumora Therapeutics, Inc. Led by Daljit Singh Aurora, public since 2023-09-15.
Snapshot as of May 15, 2026.
- Spot Price
- $1.85
- ATM IV
- 231.1%
- IV Skew 25Δ
- -1.383
- IV Rank
- 47.5%
- IV Percentile
- 89.7%
- Term Structure Slope
- -0.056
As of May 15, 2026, Neumora Therapeutics, Inc. Common Stock (NMRA) at-the-money implied volatility is 231.1%. IV rank is 47.5% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 89.7%. The 25-delta skew is -1.383: puts carry meaningful premium over calls, a classic equity downside-protection skew. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
NMRA Strategy Selection at Current Volatility Levels
For Neumora Therapeutics, Inc. Common Stock options at 231.1% ATM IV, mid-range IV rank (47.5%) is the regime where directional conviction matters more than vol-regime positioning; strategy choice should follow the event calendar and the dealer-positioning view rather than IV rank alone. The 25-delta skew is meaningfully put-skewed, so put-credit spreads capture more premium for the same width than call-credit spreads. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked NMRA volatility skew questions
- What is the current NMRA ATM implied volatility?
- As of May 15, 2026, Neumora Therapeutics, Inc. Common Stock (NMRA) at-the-money implied volatility is 231.1%. IV rank is 47.5% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is NMRA IV high or low historically?
- IV is near its 1-year median, a regime where strategy choice depends on directional conviction and event calendar rather than vol regime.
- What does NMRA volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. Neumora Therapeutics, Inc. Common Stock carries the typical equity downside-protection skew: 25-delta puts price meaningfully richer than 25-delta calls. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.